Madrigal Pharmaceuticals (MDGL) Other Accumulated Expenses (2010 - 2016)

Madrigal Pharmaceuticals (MDGL) has 7 years of Other Accumulated Expenses data on file, last reported at $1.4 million in Q2 2016.

• On a quarterly basis, Other Accumulated Expenses rose 27.08% year-over-year to $1.4 million in Q2 2016; TTM through Jun 2016 was $1.4 million, a 27.08% increase from a year earlier, with the FY2015 full-year figure at $1.0 million, down 83.21% from the prior year.
• Other Accumulated Expenses for Q2 2016 stood at $1.4 million, down from $2.8 million in the prior quarter.
• Over the last five years, Other Accumulated Expenses for MDGL reached as high as $6.2 million in Q4 2014 and fell as low as $609000.0 in Q1 2013.
• Historically, Other Accumulated Expenses has averaged $3.1 million across 5 years, with a median of $3.0 million in 2012.
• Across the five-year window, Other Accumulated Expenses soared 739.12% in 2012 and sank 83.21% in 2015, its largest moves.
• Year by year, Other Accumulated Expenses stood at $5.1 million in 2012, then increased by 11.53% to $5.7 million in 2013, then climbed by 8.03% to $6.2 million in 2014, then sank by 83.21% to $1.0 million in 2015, then surged by 39.83% to $1.4 million in 2016.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $1.4 million in Q2 2016, $2.8 million in Q1 2016, and $1.0 million in Q4 2015.